PARP1 and cancer: Given the role of EMT in metastasis, and macroH2A1.1’s role in inhibiting PARP-1 activity, our findings could provide insight into understanding EMT progression, and potentially provide a new mechanism as to how macroH2A1 expression affects cancer progression.